Modulation of Th1- and Th2-like cytokine production from mitogen-stimulated human peripheral blood mononuclear cells by phosphodiesterase inhibitors

General Pharmacology

Volumn 30, Issue 2, 1998, Pages 175-180

  Yoshimura, Tomoaki ^a   Nagao, Tomomi ^a   Nakao, Toshiya ^a   Watanabe, Shino ^a   Usami, Eiseki ^a   Kobayashi, Joji ^a   Yamazaki, Futoshi ^a   Tanaka, Hiroyuki ^b   Inagaki, Naoki ^b   Nagai, Hiroichi ^b  

^a OGAKI MUNICIPAL HOSPITAL   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Cyclic AMP; Interferon (IFN ); Interleukin 2 (IL 2); Interleukin 4 (IL 4); Interleukin 5 (IL 5); Phosphodiesterase inhibitor

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUCLADESINE; CYCLIC AMP; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MILRINONE; PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; PHYTOHEMAGGLUTININ; PROCATEROL; ROLIPRAM; THEOPHYLLINE;

ARTICLE; BLOOD; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

ADRENERGIC BETA-AGONISTS; BUCLADESINE; HUMANS; INTERFERON TYPE II; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; MILRINONE; MITOGENS; PHOSPHODIESTERASE INHIBITORS; PYRIDONES; PYRROLIDINONES; ROLIPRAM; TH1 CELLS; TH2 CELLS; THEOPHYLLINE;

EID: 0032008161     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(97)00103-1     Document Type: Article

References (28)

1. 2 and other cyclic AMP-elevating agents modulate IL-2 and IL-2Rα gene expression at multiple levels. J. Immunol. 148, 2845-2852.
2. Beavo J. A. (1988) Multiple isozymes of cyclic nucleotide phosphodiesterase. Adv. Second Messenger Phosphoprot. Res. 22, 1-38.
3. 2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol. 146, 108-113.
4. Boer J., Philpott A. J., Amsterdam R. G. M., Shahid M., Zaagsma J. and Nicholson C. D. (1992) Human bronchial cyclic nucleotide phosphodiesterase isoenzymes: biochemical and pharmacological analysis using selective inhibitors. Br. J. Pharmac. 106, 1028-1034.
5. Chan S. C., Li S. H. and Hanifin J. M. (1993) increased interleukin-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition. J. Invest. Dermatol. 100, 681-684.
6. Coskey L, A., Bitting J. and Roth M. D. (1993) Inhibition of natural killer cell activity by therapeutic levels of theophylline. Am. J. Respir. Cell Mol. Biol. 9, 659-665.
7. Crescioli S., Spinazzi A., Plebani M., Pozzani M., Mapp C. E., Boschetto P. and Fabbri L. M. (1991) Theophylline inhibits early and late asthmatic reaction induced by allergens in asthmatic subjects. Ann. Allergy 66, 245-251.
8. Del Prete G. F., Carli M., Mastromauro C., Biagiotti R., Macchia D., Falagiani P., Ricci M. and Romagnani S. (1991) Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production. J. Clin. Invest. 88, 346-350.
9. Essayan D. M., Kagey-Sobotka A., Lichtenstein L. M. and Huang S. K. (1993) Modulation of allergen-induced cytokine gene expression and proliferation by phosphodiesterase (PDE) inhibitors in vitro. J. Allergy Clin. Immunol. 91, 254.
10. + T cell subset with an unrestricted cytokine profile. J. Immunol. 143, 518-525.
11. + T cells while decreasing IL-2 release and NF-AT induction. Int. Immunol. 6, 1333-1343.
12. Lagente V., Pruniaux M. P., Junien J. L. and Moodley I. (1995) Modulation of cytokine-induced eosinophil infiltration by phosphodiesterase inhibitors. Am. J. Respir. Cri. Care Med. 151, 1720-1724.
13. Mary D., Aussel C., Ferrua B. and Fehlmann M. (1987) Regulation of interleukin 2 synthesis by cAMP in human T cells. J. Immunol. 139, 1179-1184.
14. Mosmann T. R. and Coffman R. L (1989) Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann. Rev. Immunol 7, 145-173.
15. Novak T. J. and Rothenberg E. V. (1990) cAMP inhibits induction of interleukin 2 but not of interleukin 4 in T cells. Proc. Nad. Acad. Sci. USA 87, 9353-9357.
16. + T cell clones. J. Immunol. 141, 849-855.
17. Pang D. C., Cantor E., Hagedorn A., Erhardt P. and Wiggins J. (1988) Tissue specificity of cAMP-phosphodiesterase inhibitors: rolipram, amrinone, milrinone, enoximone, piroximone, and imazodan. Drug Devel. Res. 14, 141-149.
18. Pauwels R. A. (1989) New aspects of the therapeutic potential of theophylline in asthma. J. Allerg. Clin. Immunol. 83, 548-553.
19. Robicsek S. A., Blanchard D. K., Djeu J. Y., Krzanowski J. J., Szentivanyi A. and Polson J. B. (1991) Multiple high-affinity cAMP-phosphodiesterases in human T-lymphocytes. Biochem. Pharmac. 42, 869-877.
20. Schmidt J., Hatzelmann A., Fleissner S., Heimann-Weitschat I., Lindstaedt R. and Szelenyi I. (1995) Effect of phosphodiesterase inhibition on IL-4 and IL-5 production of the murine ThZ-type T cell clone D10.G4.1. Immunopharmacology 30, 191-198.
21. Scordamaglia A., Ciprandi G., Ruffoni S., Caria M., Paolieri F., Venuti D. and Canonica G. W. (1988) Theophylline and the immune response: in vitro and in vivo effects. Clin. Immunol. Immunopathol. 48, 238-246.
22. Semmler J., Gebert U., Eisenhut T., Moeller J., Schonharting M. M., Allera A. and Endres S. (1993) Xanthine derivatives: comparison between suppression of tumour necrosis factor-α production and inhibition of cAMP phosphodiesterase activity. Immunology 78, 520-525.
23. Takatsu K. (1992) lnterleukin-5. Curr. Opin. Immunol. 4, 299-306.
24. Verghese M. W., McConnell R. T., Strickland A. B., Gooding R. C., Stimpson S. A., Yarnall D. P., Taylor J. D. and Furdon P. J. (1995) Differential regulation of human monocyte-derived TNF-α and IL-1β by type IV cAMP phosphodiesterase (cAMP-PDE) inhibitors. J. Pharmac. Exp. Ther. 272, 1313-1320.
25. 2 on ThO-type human T cell clones: modulation of functions of nuclear proteins involved in cytokine production. Int. Immunol. 6, 523-532.
26. + T lymphocytes in atopic patients. J. Immunol. 144, 4651-4656.
27. Wierenga E. A., Snoek M., Jansen H. M., Bos J. D., Lier R. A. W. and Kapsenberg M. L. (1991) Human atopen-specific types 1 and 2 T helper cell clones. J. Immunol. 147, 2942-2949.
28. Yoshimura T., Kurita C., Nagao T., Usami E., Nakao T., Watanabe S., Kobayashi J., Yamazaki F., Tanaka H. and Nagai H. (1997) Effects of cAMP-phosphodiesterase isozyme inhibitors on cytokines production by lipopolysaccharide-stimulated human peripheral blood mononuclear cells. Gen. Pharmac. 29, 633-638.